(株)医学生物学研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証JQS | 医薬品 | 4557/E00978 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/12/18 | 日証協 | 19,500株 | -91.97% | 3,898株 | -98.2% | 21,906株 | -19.48% | 32,604株 | +197.02% |
2020/12/11 | 日証協 | 242,800株 | +459.18% | 217,100株 | +436.05% | 27,206株 | -39.58% | 10,977株 | -83.98% |
2020/12/04 | 日証協 | 43,421株 | -41.73% | 40,500株 | +246.15% | 45,027株 | -23.2% | 68,500株 | +1493.02% |
2020/11/27 | 日証協 | 74,521株 | -18.04% | 11,700株 | +85.71% | 58,627株 | -48.4% | 4,300株 | -91.99% |
2020/11/20 | 日証協 | 90,921株 | -34.03% | 6,300株 | -80.62% | 113,627株 | +7.57% | 53,700株 | +237.74% |
2020/11/13 | 日証協 | 137,821株 | -12.23% | 32,500株 | -9.72% | 105,627株 | -13.15% | 15,900株 | -15.43% |
2020/11/06 | 日証協 | 157,021株 | -33.72% | 36,000株 | -39.09% | 121,627株 | -34.86% | 18,800株 | -43.37% |
2020/10/30 | 日証協 | 236,921株 | +17.92% | 59,100株 | +34.62% | 186,727株 | +8.12% | 33,200株 | +61.93% |
2020/10/23 | 日証協 | 200,921株 | +1.52% | 43,900株 | +46.33% | 172,699株 | -0.06% | 20,503株 | -29.84% |
2020/10/16 | 日証協 | 197,921株 | -1.39% | 30,000株 | +39.53% | 172,799株 | -8.42% | 29,225株 | +44.68% |
2020/10/09 | 日証協 | 200,721株 | -7.08% | 21,500株 | +162.2% | 188,679株 | -10.06% | 20,200株 | -26.56% |
2020/10/02 | 日証協 | 216,021株 | -2.75% | 8,200株 | -62.21% | 209,779株 | -1.08% | 27,506株 | -66.13% |
2020/09/25 | 日証協 | 222,121株 | -1.51% | 21,700株 | +301.85% | 212,069株 | +23.97% | 81,205株 | +316.39% |
2020/09/18 | 日証協 | 225,521株 | -5.84% | 5,400株 | -73.66% | 171,069株 | +4.19% | 19,502株 | +163.18% |
2020/09/11 | 日証協 | 239,521株 | +9.21% | 20,500株 | -68.41% | 164,182株 | +3.34% | 7,410株 | -28.78% |
2020/09/04 | 日証協 | 219,321株 | -3.48% | 64,900株 | +165.98% | 158,872株 | -2.63% | 10,405株 | +37.91% |
2020/08/28 | 日証協 | 227,221株 | +2.07% | 24,400株 | +177.27% | 163,167株 | +0.03% | 7,545株 | -26.82% |
2020/08/21 | 日証協 | 222,621株 | -8.13% | 8,800株 | -83.29% | 163,117株 | -7.22% | 10,310株 | +19% |
2020/08/14 | 日証協 | 242,321株 | +2.76% | 52,654株 | -24.18% | 175,817株 | +0.86% | 8,664株 | -74.17% |
※株式分割は考慮していませんのでご注意ください。
Page Top